These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19812601)

  • 1. Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model.
    Di Zenzo G; Calabresi V; Olasz EB; Zambruno G; Yancey KB
    J Invest Dermatol; 2010 Apr; 130(4):1040-7. PubMed ID: 19812601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice.
    Olasz EB; Roh J; Yee CL; Arita K; Akiyama M; Shimizu H; Vogel JC; Yancey KB
    J Invest Dermatol; 2007 Dec; 127(12):2807-17. PubMed ID: 17657247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models.
    Ujiie H; Yoshimoto N; Natsuga K; Muramatsu K; Iwata H; Nishie W; Shimizu H
    Front Immunol; 2019; 10():1410. PubMed ID: 31275329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does intramolecular epitope spreading occur in BPAG2 (BP180)?
    Hashimoto T; Hamada T; Dainichi T; Ishii N; Karashima T; Nakama T; Yasumoto S
    J Invest Dermatol; 2010 Apr; 130(4):924-6. PubMed ID: 20231831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
    Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
    J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
    Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H
    J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous gene gun delivery of hNC16A Induces BPAG2-specific tolerance.
    Ettinger M; Peckl-Schmid D; Gruber C; Laimer M; Thalhamer J; Hintner H; Gratz IK; Bauer JW
    J Invest Dermatol; 2012 Jun; 132(6):1665-71. PubMed ID: 22377765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy.
    Lanschuetzer CM; Olasz EB; Lazarova Z; Yancey KB
    J Invest Dermatol; 2009 May; 129(5):1203-7. PubMed ID: 19037236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses.
    Laffitte E; Skaria M; Jaunin F; Tamm K; Saurat JH; Favre B; Borradori L
    Br J Dermatol; 2001 Apr; 144(4):760-8. PubMed ID: 11298534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
    Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
    Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
    Leighty L; Li N; Diaz LA; Liu Z
    Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid: What's ahead?
    Furue M; Kadono T
    J Dermatol; 2016 Mar; 43(3):237-40. PubMed ID: 26603373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies.
    Di Zenzo G; Calabresi V; Grosso F; Caproni M; Ruffelli M; Zambruno G
    J Invest Dermatol; 2007 Apr; 127(4):864-73. PubMed ID: 17068480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of a cDNA encoding the porcine type XVII collagen noncollagenous 16 A domain and localization of the domain to the upper part of porcine skin basement membrane zone.
    Xu L; Olivry T; Chan LS
    Vet Dermatol; 2004 Jun; 15(3):146-51. PubMed ID: 15214950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.
    Hirose M; Recke A; Beckmann T; Shimizu A; Ishiko A; Bieber K; Westermann J; Zillikens D; Schmidt E; Ludwig RJ
    J Immunol; 2011 Aug; 187(3):1176-83. PubMed ID: 21705619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
    Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
    J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.